INSIGHTS ON LIQUID DOSE MANUFACTURING

  • Enable Low Volume Delivery Of Proteins In Aqueous Solutions
    11/7/2025

    Achieve ultra-low volume dispensing of proteins and aqueous solutions without surfactants with consistent precision, minimal contamination, and broad compatibility to streamline your lab workflow.

  • CDMO Partnerships: Why Speed And Flexibility Matter Now More Than Ever
    12/29/2025

    As demand for GLP-1s and biologics accelerates and timelines compress, it's become more crucial that pharmaceutical companies stay competitive and bring therapies to market faster by partnering with a CDMO.

  • CDMO Checklist To Choose The Right Aseptic Isolator
    1/9/2026

    Selecting the right isolator for aseptic filling requires more than comparing features. Discover essential questions to ask and make informed decisions that align with your process and operational goals.

  • A Standardized Gloveless Robotic Isolator
    10/16/2024

    By eliminating human intervention—the primary risk factor compromising drug sterility and quality—gloveless aseptic processing technology offers manufacturers greater flexibility, safety, and regulatory compliance in their filling operations.

  • Step Into The Future Of ATMP Fill-Finish
    5/21/2025

    Discover the future of ATMP manufacturing as Josh Russell from AST demonstrates an advanced, fully automated fill-finish system featuring automated bag and tub opening, as well as the Atmos isolator.

LIQUID DOSE MANUFACTURING SOLUTIONS

  • Used 12.26 sq meter (131.91 sq ft) BOC IMA freeze dryer, model LyoMax12, 316L stainless steel product contact surfaces, wth (12) total, (11) usable shelves, 914mm x 1219MM x 15mm thick shelves, 145mm shelf spacing, top down stoppering, rated to -60 c min temperature, slotted doors with unloading system, 17 sq meter external condensor, 345 kg ice capacity, (3) 30 hp Mycom refrigeration compressors, (2) EH250 Edwards vacuum pumps, SIP/CIP capable, Allen Bradley controls, 480 volt, serial# FD2889, built 1996.

  • Dec offers filling lines for both liquids and solids for the aseptic fill-finish process that require high containment equipment.

  • A global partner offering prefillable drug‑delivery systems, manufacturing expertise, and integrated services that accelerate development, secure supply, and support therapies across multiple areas.

  • AST’s ASEPTiCell® is a flexible fill/finish system that can efficiently process medium-sized clinical and commercial batches while meeting all cGMP requirements for cleanliness and sterility.

  • The Microcell™ Vial Filler is a closed robotic isolator for pharmaceutical vial filling that enables small batch flexibility and standardized manufacturing.